by NMS | Nov 22, 2023 | 2023, News
Nerviano_2023-09-01_NerPharMa Srl (NerPharMa), a leading Contract Development and Manufacturing Organization (CDMO), is pleased to announce the appointment of Claudio Salvagnini as the Deputy CEO, effective immediately. Since Claudio joined the leadership team earlier...
by NMS | Nov 15, 2023 | 2023, News
We are pleased to announce that Dr. Gianluca Papeo and Dr. Maurizio Pulici from NMS Srl are invited to be part of the permanent round table of the Pharmaceutical Division of the Italian Chemical Society (SCI) which gathers representative of the Italian Pharmaceutical...
by NMS | Nov 2, 2023 | 2023, News
NERVIANO, IT and BOSTON, Mass, November 2, 2023 – Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc., a wholly owned subsidiary of NMS Group, focused on the discovery and early development of oncology...
by NMS | Oct 12, 2023 | 2023, News
Nerviano Medical Sciences Presents Preliminary, Encouraging Clinical Phase 1 Data for PARP-1 Selective Inhibitor at the 35th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics NERVIANO, IT and BOSTON, Mass, October 12, 2023 –...
by NMS | Oct 9, 2023 | 2023, Events, News
We are attending the 2023 BIO Europe partnering event in Munich, Germany. NMS Group- Nerviano Medical Sciences will participate to the 2023 BIO Europe partnering event, which will be held in Munich from November 6th to 8th, 2023 and online from November 14th to 15th,...
Welcome and Check out our new motion picture!
Recent Comments